fda semaglutide compound Despite ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market FDA Moves to Close a

([BioRxiv][7]) 8

Recent advances in cardiovascular disease research driven by metabolomics technologies in the context of systems biology

A microdose program stays in the gentle range and does not titrate up

Animal studies by Carla Nasca, a postdoctoral scholar in McEwens lab, suggest that acetyl-L-carnitine, a crucial mediator of fat metabolism and energy production throughout the body, plays a special role in the brain, where it works at least in part by preventing the excessive firing of excitatory nerve cells in brain regions called the hippocampus and frontal cortex

Proper mixing is not complicated, but doing it wrong costs money

doi: 10.2337/dc23-1135